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Frozen section histological analysis is currently the mainstay for intraprocedural tissue diagnosis 
during the resection of intracranial neoplasms and for evaluating tumor margins. However, 
frozen sections are time-consuming and often do not reveal the histological features needed 
for final diagnosis when compared with permanent sections. Confocal scanning microscopy 
(CSM) with certain stains may be a valuable technology that can add rapid and detailed 
histological assessment advantage for the neurosurgical operating room. This study describes 
potential advantages of CSM imaging of fresh human brain tumor tissues labeled with 
acriflavine (AF), acridine orange (AO), cresyl violet (CV), methylene blue (MB), and indocyanine 
green (ICG) within the neurosurgical operating room facility. 
Patients and methods 
Acute slices from orthotopic human intracranial neoplasms were incubated with AF/AO and CV 
solutions for 10 s and 1 min respectively. Staining was also attempted with MB and ICG. 
Samples were imaged using a bench-top CSM system. Histopathologic features of 
corresponding CSM and permanent hematoxylin and eosin images were reviewed for each 
case. 
Results 
Of 106 cases, 30 were meningiomas, 19 gliomas, 13 pituitary adenomas, 9 metastases, 6 
schwannomas, 4 ependymomas, and 25 other pathologies. CSM using rapid fluorophores (AF, 
AO, CV) revealed striking microvascular, cellular and subcellular structures that correlated with 
conventional histology. By rapidly staining and optically sectioning freshly resected tissue, 
images were generated for intraoperative consultations in less than one minute. With this 




CSM of fresh human brain tumor tissue provides clinically meaningful and rapid 
histopathological assessment much faster than frozen section. With appropriate stains, 
including specific cellular structure or antibody staining, CSM could improve the timeliness of 
intraoperative decision-making, and the neurosurgical-pathology workflow during resection of 
human brain tumors, ultimately improving patient care.
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It is estimated that nearly 78,000 people in the U.S. develop brain and central nervous system 
neoplasms each year [1]. Initial work up of these lesions often includes stereotactic biopsy to 
identify histological diagnosis and further management [2]. Certainly, the intraoperative 
histology guides resection strategy and optimizes tissue banking [3,4]. Frozen sections are the 
current gold standard for intraoperative diagnosis and are small biopsy specimens often sent 
initially from the main tumor mass, and then from the suspected tumor boundary region as the 
surgery progresses. Frozen section histology usually correlates with analysis of the tissue for 
permanent histology for final diagnosis [4]. However, the diagnostic discrepancy between 
frozen and permanent sections is reported to be as high as 2.7% [5]. Frozen section histology 
implements only simple staining techniques and requires 15–40 min of processing time [6]. 
Freezing or cautery artifacts can affect the diagnostic accuracy [7]. Artifacts and sampling error 
reduce diagnostic yield and often require harvest of additional biopsy specimens, which 
significantly increases surgery and anesthesia times. 
Confocal scanning microscopy (CSM) has become an accepted, powerful, standard research 
technique for investigations into tumor cell biology. Samples can be imaged utilizing a variety of 
specific and non-specific fluorophores or intrinsic tissue fluorescence [[8], [9], [10], [11]]. This 
technology would seem to be well poised to be propitiously adopted into dedicated clinical use, 
especially for neurosurgical tumor procedures. So far, however, the high equipment cost and 
requirement for specialists versed in CSM imaging has impeded wide implementation of this 
technology in clinical settings [12]. 
Unlike frozen sections, fresh tissue samples near immediately stained with rapid-acting 
fluorophores are not affected with freezing artifacts and do not require a lengthy period of 
tissue preparation [13]. Utilization of rapid-acting fluorophores could significantly reduce the 
time needed to provide feedback during intraoperative histopathological consultation, improve 
intraoperative decision-making, and potentially reduce surgery and anesthesia times [10,13,14]. 
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The goal of this article is to describe and assess performance and feasibility of CSM to image 
fresh human brain tumor tissue biopsies labeled with rapid staining fluorophores within the 
time of surgery. The fluorophores used in this study were chosen because they provide 
immediate staining of the tissue, thus minimizing the time between intraoperative tissue 
harvest and histologic data acquisition [10,11,13,14]. 
  
3 
Materials and methods 
This study was approved by the Institutional Review Board at the Barrow Neurological Institute, 
St. Joseph’s Hospital and Medical Center. Patients with intracranial neoplasms requiring 
craniotomy for surgical resection were eligible for the study. Over a sequential 6-month period, 
106 patients were prospectively enrolled in this study. The exclusion criteria included age 
younger than 18 years and inability to sign informed consent. 
2.1. Tissue sampling 
Intraoperative image-guided neurosurgical technique was used in all patients (StealthStation 
Surgical Navigation, Medtronic, Inc., Dublin, Ireland). All enrolled patients underwent 
craniotomy. The dura was opened and an approach to the tumor was performed. Standard 
microsurgical biopsy technique was used to harvest tissue samples from areas corresponding 
with contrast enhancement on co-localized contrast-enhanced T1-weighted MRI images 
[13,14]. Tissue samples were stored in vials containing ice-cold artificial cerebrospinal fluid to 
ensure preservation of the viable tissue. Artificial cerebrospinal fluid contained the following 
components (in mM): 126 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2 and 10 
glucose, pH 7.4 [15]. Samples were transferred to the pathology department for imaging with 
the CSM. There were a total of 6 samples from each patient (approximate volume 0.25 cm3 
each). Each sample was placed into a No 1.5 glass bottom dish (MatTek, Ashland, MA) for CSM 
imaging (Fig. 1). 
2.2. Fluorophores 
Rapid-staining fluorophores selected for this study were: acriflavine hydrochloride (AF), acridine 
orange (AO), cresyl violet (CV), methylene blue (MB), indocyanine green (ICG) (Table 1). A 
control sample was imaged without addition of fluorophores from each patient. The optimal 
staining time was calculated for each fluorophore. These fluorophores were selected because 
our group has had significant experience with their use in confocal laser endomicroscopy of 
brain tumor tissue and because of their convenient employment for CSM [10,13,14,16]. 
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2.3. Confocal scanning microscopy 
CSM was performed with a Zeiss LSM 710/5Live DUO system (Carl Zeiss AG, Oberkochen, 
Germany). A set of 3 images was taken with different magnifications (24×, 40× and 60×) for 
each sample. In addition, large simulated low-magnification images were acquired from the 
samples and sequential images were transformed into digital image video loops. Fluorophore-
labeled samples were placed onto the motorized stage of the CSM equipped with a 40×/1.2NA 
water emersion objection. Acriflavine, AO, CV, MB, and ICG were imaged with the following 
excitation/full width at half maximum emission spectra respectively: 405/545 nm, 489/615 nm, 
561/684 nm, 633/707 nm and 635/670 nm. The confocal aperture was set to one Airy unit for 
all imaging. The laser and gain values were set to fill the dynamic range of the photomultiplier 
tubes, and the frame size was set to sample at Nyquist. Images were collected in 8- and 12-bit 
format absent of non-linear processing. Simulated low magnification images were acquired by 
adjusting the digital zoom to 24× and 900 μm2 fields of view were collected with automated 
image tilling. In some cases, images from entire samples were rapidly tiled and optically 
sectioned using a Zeiss line-sweeping CSM. Frame size for this system was fixed to 512 × 512 by 
a linear charged coupled device (CCD) array. The total imaging time was calculated for each 
sample and patient. 
2.4. Histology and data processing 
Imaging sites of the tissue samples were marked with ink to obtain matched CSM and 
conventional histological sections. Samples were placed into the tissue cassette for further 
formalin fixation and paraffin embedding. Ten micrometer tissue sections were obtained for 
hematoxylin and eosin staining (H&E) and light microscopy. Matched CSM images and 
permanent sections were reviewed by a group of 2 neuropathologists and 3 neurosurgeons. 
The cytoarchitecture and histopathologic features were identified and compared between CSM 





Fig. 1. Tissue sampling and imaging set up. (A) Tissue samples embedded in (left to right) AF, 
ICG, CV, AO, artificial cerebrospinal fluid. (B) Setup of the confocal microscope. Used with 






One-hundred and six consecutive patients (48 females and 58 males) were prospectively 
enrolled in this study with mean age of 53 years (range 18–84). Each patient had a total of six 
samples imaged with a variety of fluorophores. There were 1960 CSM images acquired in this 
study (19 images per patient). Total imaging time was 20 min per patient. Average time from 
specimen arrival to the pathology department to obtaining the first CSM image was 
one minute. Average time to obtain frozen sections results in this study was 15 minutes from 
the specimen arrival to the pathology department. CSM images were saved as video loops in 
digital format and could be electronically transferred to an offsite neuropathologist within a 
few minutes (Supplemental Video 1). 
3.1. Fluorophores 
AF and AO provided instant fluorescence with high clarity and contrast of histopathologic 
features. Because of that characteristic, AF and AO-stained samples were imaged first. Both AF 
and AO produced high-quality staining of extracellular and intracellular structures, 
predominantly nuclei and cellular membranes revealing detailed images. However, AF had a 
propensity to label more extracellular structures than AO. In some cases, AF obscured 
interpretation of the intracellular structures. AF and AO provided good quality fluorescence in 
all cases, except for cavernous malformations. 
CV staining generated an optimal fluorescent appearance within five to six minutes. Unlike AF 
and AO that stained nuclei primarily, CV caused diffuse fluorescence of the cytoplasm that 
highlighted large diffuse areas of the image. Cell morphology was defined by fluorescent 
cytoplasm encased within the cell membrane; intracellular components were identified as dark 
silhouettes over bright fluorescent cytoplasm. CV provided high quality images, however 
nucleoli were not identifiable compared with AO or AF stains. 
MB and ICG exhibited minimal fluorescence with the described staining procedures and imaging 
techniques. No meaningful histopathological patterns were identified. 
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One sample from each patient was imaged using the described CSM imaging parameters, but 
without addition of fluorophores. The identified auto fluorescence was minimal and did not 
overlap with signals associated with any of the fluorophores. 
3.2. Histopathology 
The final diagnoses in the cases in this study included: 30 meningiomas (World Health 
Organization [WHO] Grade I [n = 28], II [n = 2]), 19 gliomas (WHO Grade II [n = 5], Grade III 
[n = 3], and Grade IV [n = 11]). The rest of the 57 cases included 13 pituitary adenomas, nine 
metastases, seven cavernous malformations, six schwannomas, five subependymomas, four 
ependymomas, three radiation necroses/gliosis and one each for chordoma, 
craniopharyngioma, fibrous dysplasia, hemangiopericytoma, primary CNS lymphoma, nerve 
sheath tumor, neurocytoma, paraganglioma, pleomorphic xanthoastrocytoma, squamous cell 
carcinoma (Table 2). 
Meningiomas were best visualized with AF and AO staining. The quality of CV staining was not 
consistent. Amongst 30 meningiomas 13 were transitional, nine meningothelial, two atypical, 
four fibrous, and two secretory. Meningiomas stained with AF and AO demonstrated whorls of 
oval to spindled cells with various amounts of pericellular collagen proliferating in a vesicular 
pattern. Psammoma bodies could be seen in multiple cases. Secretory meningiomas had 
characteristic secretory inclusions and cytoplasmic laminae. Atypia was apparent in WHO Gr II 
meningiomas. The correct diagnosis and subtype could be identified in 26 cases (86.7%). In 
three cases (10%) (fibrous and meningothelial meningiomas) it was possible to identify 
meningioma although subtyping was not accurate. In one case (transitional meningioma) the 
diagnosis could not be identified due to poor image quality (Fig. 2). 
Gliomas were better visualized with AF and AO staining. Staining with CV did not provide 
reliable histological information in all cases, although based on CV staining in anaplastic 
oligodendrogliomas, mitotic figures, microvascular proliferation, and tumor necrosis were 
identifiable. Hypercellularity with diffuse parenchymal infiltration and dystrophic calcifications 
with adjacent intermingled tumor cells were readily noted. Tumor cells had round to oval nuclei 
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and apparent fibrillary processes. Atypical features were also visualized. The correct diagnosis 
of glioma was made in 17 of 19 cases (89.0%). The correct subtyping was possible in four cases 
(21.0%) (three glioblastomas, one oligodendroglioma). In two cases (glioblastoma, 
oligodendroglioma) the diagnosis could not be identified due to poor image quality (Fig. 3). 
Treatment effect presented as large areas of pseudonormal brain tissue pattern showing non-
neoplastic reactive changes with high macrophage content. 
Pituitary adenomas demonstrated sheets of round to oval cells with prominent nuclei and a 
moderate amount of bright cytoplasm with CV. Normal pituitary cells appeared smaller with 
less pleomorphic nuclei than neoplastic pituitary epithelial cells with AO and AF. The correct 
diagnosis could be determined for all pituitary adenoma cases in this study (n = 13). 
There were nine cases of metastatic disease in this series (six adenocarcinomas, three 
carcinomas). These lesions were optimally stained with AO and AF. Fluorescence in 
adenocarcinomas showed sheets of cells with or without gland formation. Atypical cells 
contained rich bright cytoplasm with secretory granules. In cases with gland formation, there 
was necrotic debris filling the gland. In one case of metastatic clear cell carcinoma, invading 
cells with prominent clear cytoplasm were noted. Correct diagnosis was possible in five of nine  
cases (four metastatic adenocarcinomas, one metastatic carcinoma) (55.6%). In the remaining 
four cases, although atypical cells were identified, correct diagnosis was not possible with CSM 
imaging. 
Schwannomas represented six cases in this study. Staining with AO and AF provided informative 
images that correlated with conventional H&E. In all cases spindled cells and nuclei were 
apparent. Antoni A and B areas were identified in all cases. In two cases verocay bodies were 
apparent. Correct diagnosis was made in all six cases (Fig. 4). 
Subependymomas staining revealed clusters of isomorphic nuclei embedded in a dense, fine, 
glial fibrillary background. They were best identified with AF, however, AO also provided 
important complimentary histopathologic data. Of five cases, correct diagnosis was possible 
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only in three (60%). In the remaining two cases, although atypical cells were identified, the 
correct diagnosis was not possible because of insufficient histopathologic data. 
Ependymoma fluorescence appearance showed cells with round to oval nuclei with only mild 
atypia. There was distinct arrangement of tumor cells into perivascular pseudorosettes in one 
case. AF and AO provided the most informative histopathologic information. Correct diagnosis 
was possible in only one case (25%). In three cases (75%), atypical cells were identified, but 
histopathologic information derived from CSM images was not sufficient to determine the 
diagnosis. 
A central neuroctyoma revealed proliferation of neoplastic cells arranged in diffuse sheets and 
nests and was best visualized with AF and AO (Fig. 5). The tumor cells were embedded in a 
background of fine fibrillary stroma. The individual cells demonstrated round nuclei with fine 
chromatin. Mitotic figures were not identified. 
Squamous cell carcinoma presented as multiple nests of infiltrating moderately differentiated 
squamous carcinoma with scattered mitosis and was best visualized with AF and AO. Tumor 
cells had atypical large nuclei and abundant cytoplasm. 
Cavernous malformations did not exhibit an informative fluorescent histologic pattern with any 
fluorophore used in this study. 
There were 99 patients with true neoplastic or related processes in this study seven cases of 
cavernous malformations were not included in this analysis). In 66 cases (66.7%) CSM correctly 
identified the diagnosis including tumor subtype when compared to conventional 
histopathologic analysis (Table 3). In five patients (5.1%) CSM images did not contain useful 
diagnostic information (Table 4). In 28 patients (28.3%) CSM identified a neoplastic process, 




3.3. Volumetric imaging 
CSM can scan the entire tissue sample by shifting the field of view. In addition, virtual image 
slices along the Z-axis allowed volumetric analysis of the tissue. We scanned with the 488 nm 
laser range to a depth of about 50 μm. Also, CSM allowed increase or decrease of magnification 
for more detailed analysis of the tumor cells or area of interest and navigation software allowed 




Table 2. Frequency of histopathologies in this study 
  Number of patients 
Meningioma 30 
Glioma 19 
Pituitary adenoma 13 
Metastasis 9 








Fibrous dysplasia 1 
Hemangiopericytoma 1 
Primary CNS lymphoma 1 
Nerve sheath tumor 1 
Neurocytoma 1 
Paraganglioma 1 
Pleomorphic xanthoastrocytoma 1 




Fig. 2. Meningothelial meningioma. Ex vivo confocal images (A–F) obtained in case 
meningothelial meningioma. (A, B) stained with AO, (C, D) stained with AF, (E, F) stained with 
CV. (G) photomicrograph of H & E–stained sections showing histopathological features of 
whorls, psammoma bodies, and collagen similar to those of the matched imaging location. 
Original magnification ×200 (A, C, E, G) and ×400 (B, D, F). Used with permission from Barrow 
Neurological Institute, Phoenix, Arizona, USA.  
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Fig. 3. Glioblastoma. Ex vivo confocal images (A–F) obtained in case glioblastoma. (A, B) stained 
with AO, (C, D) stained with AF, (E, F) stained with CV. (G) photomicrograph of H & E–stained 
sections showing histopathological features of cellular tumor with hypercellularity, atypia, and 
neovascularization similar to those of the matched imaging location. Original magnification 
×200 (A, C, E, G) and ×400 (B, D, F). Used with permission from Barrow Neurological Institute, 




Fig. 4. Schwannoma. Ex vivo confocal images (A–F) obtained in case glioblastoma. (A, B) stained 
with AO, (C, D) stained with AF, (E, F) stained with CV. (G) photomicrograph of H & E–stained 
sections showing histopathological features of cellular tumor with fascicles of cells with 
elongated cytoplasmic processes. Original magnification ×200 (A, C, E, G) and ×400 (B, D, F). 




Fig. 5. Central neurocytoma. Ex vivo confocal images (A–D) obtained in case glioblastoma. (A, B) 
stained with AO, (C, D) stained with AF. (E) photomicrograph of H & E–stained sections showing 
histopathological features tumor cells embedded in a background of fine fibrillary stroma. The 
individual cells demonstrate round nuclei. Original magnification ×200 (A, C, E) and ×400 (B, D). 
Used with permission from Barrow Neurological Institute, Phoenix, Arizona, USA. 
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n % n % n %  
Meningioma 26 87% 3 10% 1 3% 30 
Glioma 4 21% 13 68% 2 11% 19 
Pituitary adenoma 13 100% 0 0% 0 0% 13 
Metastasis 5 56% 4 44% 0 0% 9 
Cavernous 
malformation 
0 0% 0 0% 7 100% 7 
Schwannoma 6 100% 0 0% 0 0% 6 
Subependymoma 3 60% 2 40% 0 0% 5 
Ependymoma 3 75% 1 25% 0 0% 4 
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Table 4. Cases with no diagnostic images 
Cases with no diagnostic images Number of cases 
Cavernous malformation 7 
Oligodendroglioma 1 
Glioblastoma 1 
Transitional meningioma 1 
Craniophryngioma adamantinous 1 
Fibrous dysplasia 1 
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Table 5. Cases with images with distinguishable tumor. No subtyping possible. 




Metastatic colon carcinoma 2 
Subependymoma 2 
Fibrous meningioma 1 
Meningothelial meningoioma 1 
Transitional meningioma 1 
Anaplastic oligodendroglima 2 
Anaplastic astrocytoma 1 
Metastatic poorly differentiated adenocarcinoma 1 
Metastasis lung adenocarcinoma 1 
Paraganglioma 1 





This study assesses the feasibility of CSM as a dedicated imaging platform that is aimed at 
consistently augmenting a neurosurgical oncology and pathology workflow. Fluorescent 
microscopy technologies have been actively studied to improve precision of surgery and 
complement histological analysis of biopsies. Although CSM technology can be considered as a 
forerunner of the handheld confocal laser endomicroscopes, the utility and resultant image 
quality of CSM has not been previously investigated in the neurosurgery operating room [17]. 
Our results therefore define a baseline of performance, feasibility, and diagnostic accuracy for 
CSM when applied in a clinical setting compared to what has been achieved on brain tumor 
tissue with the standard research grade benchtop CSM technology in the laboratory. 
4.1. Appearances of the fluorophores with pathology types 
Traditionally, CSM has been used for research applications [18,19]. High costs for purchase and 
technician operation in comparison to light microscopes seem to have prohibited widespread 
use of CSM into routine clinical practice. This study describes utility of a benchtop CSM system 
for rapid acquisition of fluorescent histologic information during neurosurgical tumor removal 
procedures using non-specific and specific fluorescent stains. While this experience is 
preliminary, identifying specific utility and cellular structure appearance for each fluorophore 
may improve workflow during intracranial neoplasm surgery. The variety of rapid-staining 
fluorophores examined for this study allows for identification and differentiation of 
histopathologic features. Flow of information from fluorescence staining of fresh tissue 
combined with benchtop CSM imaging was significantly faster compared to the conventional 
“frozen sections” method of initial tumor tissue assessment. 
In this study, rapidly staining fluorophores were utilized: AO, AF, CV, ICG, and MB. AO and AF 
stained tissue instantaneously, while CV required a stain time of 5–6 min and revealed a 
detailed unique histologic appearance for pituitary adenomas. Many of these dyes can be used 
in vivo for example during gastrointestinal and bronchoscopy procedures, but they cannot be 
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used in the live human brain [20,21]. Ex vivo imaging allows for use of an expanded repertoire 
of fluorophores on brain tissue, many of which are considered too toxic for in vivo use. 
A histologically meaningful fluorescence was not detected with MB or ICG at the concentrations 
and imaging parameters used in these experiments. The majority of CSMs are not equipped for 
infrared imaging. Therefore, imaging MB/ICG stained samples was performed with far-red 
imaging parameters, although MB/ICG did not produce useful images with CSM at these 
parameters either. ICG delineation of tumor cells can be seen with microscopy systems 
operating in the near-infrared laser range [11,[22], [23], [24], [25]]. 
Cavernous malformations did not stain with fluorophores used in this study. This could be 
explained by the biostructural properties of cavernous malformations. Cavernous 
malformations are not neoplasms and hypercellularity with atypia is not characteristic for these 
lesions [26,27]. Thus, they did not exhibit fluorescence patterns as observed for the neoplastic 
lesions investigated in this study. 
4.2. Acquisition of fluorescent signal 
The histopathologic features obtained with CSM were accurate and easily recognized in 66.7% 
of tumor cases when compared with conventional methods of clinical histology. The imaging 
parameters and fluorophores used in this study allowed acquisition of extremely high 
resolution images producing detail at multiple magnifications. Lower magnifications were 
useful to assess tissue cytoarchitecture, while higher magnification facilitated analysis of 
intracellular components. The CSM was capable of imaging the entire specimen quickly and 
allowed high-magnification visualization at any chosen area. These data could be stored and 
transmitted as still images and digital video loops. This imaging process can be simplified and 
automated, which could be useful for telepathology. 
In 30.3% cases where precise diagnosis was not possible, CSM images provided confirmation of 
a neoplastic process. In most of these cases the tissue sample was not large enough for CSM 
imaging with the variety of fluorophores. This situation resulted because of the small size of the 
primary lesion, where the priority was made to provide enough tissue for clinical diagnosis via 
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conventional histopathology. Although the appearance of images stained with such 
fluorophores reveals images different from conventional H&E or other stains, already many 
neuropathologists are becoming experienced with assessment of images from CSM systems 
and likewise are gaining experience with images from confocal laser endomicroscopy of ex vivo 
and in vivo brain and other organ tissue [10,[13], [14], [15],24]. 
4.3. Clinical application of confocal scanning microscopy 
Widespread adoption of CSM technology would require demonstrating utility and establishing a 
CSM platform that is refined and dedicated for clinical pathology use [28,29]. In our experience, 
the use of CSM significantly decreased the time duration to acquire histopathologic data in 
comparison with frozen sections [14]. In our series, CSM accurately detected a neoplastic 
process in 95% of cases within 1 min after the specimen arrived to pathology department. 
Results of our study with CSM are in line with previous reports that used other technologies 
including hand held confocal laser endomicroscopy for ex vivo human and animal tumor tissue 
staining, and also application of novel Raman microscopes for stainless tissue imaging [10,[30], 
[31], [32]]. Although confocal laser endomicroscopy is being investigated for its portable on-
the-fly performance within the surgical site, benchtop CSM technology can image the tissue 
specimen with a range of multiple lasers and produces comparatively better quality images. 
A CSM platform such as the system used in this study provides a wealth of powerful tissue 
analytic techniques that can add substantial cellular information over a relatively brief time, 
although not generally within the very few minutes demanded by intraoperative reporting 
currently. These applications include volumetric imaging, with depth of imaging determined by 
the laser characteristics and the tissue (in our study to about 50 μm at 488 nm). However, 
penetration into the tissue can approach 1 mm with non-linear optics add-ons that combine 
multiphoton capabilities with CSM [33,34]. Another potential improvement towards clinical use 
is application of spinning-disk technology, which increases the image acquisition speed from 
below video rate (<30 frames per second) for CSM to 200–1000 frames per second, allowing for 
instant video-like imaging at high resolution [35]. The trend is really towards providing a more 
representative and accurate imaging session for tissues in vivo [14,36,37] or rapidly ex vivo 
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[38,39] that also involves analyzing the interactions of structures. CSM navigation software 
allows the user to move throughout the tissue, and to quickly recover locations of tissue 
interest. Other capabilities that may require longer duration include photobleaching and 
photoactivation experiments that are relevant for cancer tissue examination, including cell 
death, analysis of DNA repair proteins, protein synthesis or detailed mechanisms of cell 
division. Additionally, CSM can simultaneously image multiple fluorescent dyes and single 
molecules can be imaged rapidly with advanced modules such as fluorescence correlation 
spectroscopy and image correlation spectroscopy [40]. Lastly, highly functional and integrated 





In the setting of intracranial biopsy, qualified use of CSM with appropriate fluorophores would 
be sufficient to analyze tissue and complete the procedure without additional sampling and 
could help to reduce operating room and anesthesia time for biopsy procedures. This could be 
implemented across clinical specialties beyond neurosurgery, e.g., for sentinel lymph node 
biopsy. In the setting of a multispecialty hospital where there are multiple such procedures 
performed daily, the economies of scale could exist to make it worthwhile for hospitals to 
adopt such technology. Very likely, the simplification of a research CSM system specifically 
adapted and dedicated for clinical histological imaging could potentially decrease the price per 
unit. While the fluorescent dyes we used in this study can provide additional and alternative 
histological data, application of specific labels for tissue acquired from the operating room that 
can be rapidly processed and visualized in the pathology laboratory will yield improved 
intraoperative diagnosis and influence surgical decisions. It would seem likely that CSM 
technology will be developed and refined providing more efficient machine operation and 
analysis that may be adapted for the operating room. Such technology would add a near-
immediate parameter to tissue assessment for imaging of various cell structures and detection 
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